Medicare billing address
CMS Medicare provider billing file
2701 Holme Ave Ste 303Philadelphia, PA 19152
CMS public data · NPI 1245573864
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Anton M Kolomeyer, MD, PHD
Specialty
Credential
MD, PHD
NPI
1245573864
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Anton M Kolomeyer, MD, PHD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
2701 Holme Ave Ste 303CMS Doctors & Clinicians file
501 Hyde ParkCMS Doctors & Clinicians file
251 S Lincoln AveIn the 2024 CMS provider billing file, this NPI had 984 Medicare beneficiaries and 24,305 total services. The average beneficiary age was 76, and the average HCC risk score was 1.7.
Total Medicare allowed amount
$3,591,635.61
Total Medicare payment amount
$2,823,761.26
Medicare beneficiaries
984
Total services
24,305
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Diabetes
42%
CMS beneficiary-panel share
Ischemic heart disease
35%
CMS beneficiary-panel share
Chronic kidney disease
30%
CMS beneficiary-panel share
Anxiety
22%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, faricimab-svoa, 0.1 mg | 9,660 | $34.57 |
| Injection, aflibercept hd, 1 mg | 4,368 | $329.86 |
| Injection, avacincaptad pegol, 0.1 mg | 2,220 | $108.55 |
| Imaging of retina | 2,080 | $42.42 |
| Established patient complete exam of visual system | 2,025 | $132.35 |
| Injection of drug into eye | 1,152 | $129.63 |
| Extended exam of the back part of the eye with optic nerve drawing | 1,022 | $16.04 |
| Injection, aflibercept, 1 mg | 348 | $826.64 |
| Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 307 | $229.66 |
| Unclassified biologics | 181 | $2,819.24 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1245573864. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Prednisolone Acetate | Prednisolone Acetate | 191 | 320.9 | $9,547.53 |
| 2 | Latanoprost | Latanoprost | 168 | 346.3 | $2,441.27 |
| 3 | Brimonidine Tartrate | Brimonidine Tartrate | 57 | 123.3 | $737.85 |
| 4 | Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 56 | 122.1 | $700.49 |
| 5 | Ciprofloxacin Hcl | Ciprofloxacin Hcl | 49 | 61 | $813.43 |
| 6 | Ketorolac Tromethamine | Ketorolac Tromethamine | 47 | 60.9 | $1,049.21 |
| 7 | Atropine Sulfate | Atropine Sulfate | 45 | 80 | $1,951.61 |
| 8 | Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 22 | 22 | $253.00 |
| 9 | Dorzolamide Hcl | Dorzolamide Hcl | 20 | 38.9 | $328.49 |
| 10 | Difluprednate | Difluprednate | 19 | 19.2 | $1,573.59 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
2012
Group/practice field
Associated Retinal Consultants Llc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.